Details for Patent: 10,729,667
✉ Email this page to a colleague
Which drugs does patent 10,729,667 protect, and when does it expire?
Patent 10,729,667 protects NAFTIN and is included in one NDA.
This patent has three patent family members in three countries.
Summary for Patent: 10,729,667
| Title: | Topical compositions and methods for making and using same |
| Abstract: | The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof. |
| Inventor(s): | Bhushan Hardas, Donna Dalton, Petra Scheppler, Anja Buch, Peter Boderke |
| Assignee: | Legacy Pharma Inc |
| Application Number: | US16/195,153 |
|
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 10,729,667
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Legacy Pharma | NAFTIN | naftifine hydrochloride | GEL;TOPICAL | 204286-001 | Jun 27, 2013 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,729,667
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014212201 | ⤷ Start Trial | |||
| Canada | 2899725 | ⤷ Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2014121048 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
